Market Rumors Grow On Potential GSK Purchase Of Nanjing MeiRui Pharma For Urology Expansion In China

SHANGHAI- Market rumors are growing that GlaxoSmithKline will add on to its urology franchise in China with a local acquisition

More from Archive

More from Scrip